Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases

Developmental Neuroscience

Volumn 31, Issue 5, 2009, Pages 394-402

  Sifringer, Marco ^a   Genz, Kerstin ^a   Brait, Daniela ^a   Brehmer, Felix ^a   Löber, Rebekka ^a   Weichelt, Ulrike ^a   Kaindl, Angela M ^b,d,e   Gerstner, Bettina ^a,c   Felderhoff Mueser, Ursula ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Erythropoietin; Hyperoxia; Inflammation; Matrix metalloproteinase

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 18; INTERLEUKIN 1BETA; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN INJURY; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPEROXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; CELL DEATH; ERYTHROPOIETIN; HYPEROXIA; INTERLEUKIN-18; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OXYGEN; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 68349123576     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232557     Document Type: Article

References (32)

1. Felderhoff-Mueser U, Bittigau P, Sifringer M, Jarosz B, Korobowicz E, Mahler L, Piening T, Moysich A, Grune T, Thor F, Heumann R, Buehrer C, Ikonomidou C: Oxygen causes cell death in the developing brain. Neurobiol Dis 2004; 17: 273-282.
2. Gerstner B, Sifringer M, Dzietko M, Schüller A, Lee J, Simons S, Obladen M, Volpe JJ, Rosenberg PA, Felderhoff-Mueser U: Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann Neurol 2007; 61: 562-573.
3. Dzietko M, Boos V, Sifringer M, Polley O, Gerstner B, Genz K, Endesfelder S, Boerner C, Jacotot E, Chauvier D, Obladen M, Buehrer C: A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury. Ann Neurol 2008, in press.
4. Hoehn T, Felderhoff-Mueser U, Maschewski K, Stadelmann C, Sifringer M, Bittigau P, Koehne P, Hoppenz M, Obladen M, Buehrer C: Hyperoxia causes inducible nitric oxide synthase-mediated cellular damage to the immature rat brain. Pediatr Res 2003; 54: 179-184.
5. Gerstner B, DeSilva TM, Genz K, Armstrong A, Brehmer F, Neve RL, Felderhoff-Mueser U, Volpe JJ, Rosenberg PA: Hyperoxia causes maturation-dependent cell death in the developing white matter. J Neurosci 2008; 28: 1236-1245.
6. Sirinyan M, Sennlaub F, Dorfman A, Sapieha P, Gobeil F, Hardy P, Lachapelle P, Chemtob S: Hyperoxic exposure leads to nitrative stress and ensuing microvascular degeneration and diminished brain mass and function in the immature subject. Stroke 2006; 37: 2807-2815.
7. Kaindl AM, Sifringer M, Zabel C, Nebrich G, Wacker MA, Felderhoff-Mueser U, Endes-felder S, von der Hagen M, Stefovska V, Klose J, Ikonomidou C: Acute and long-term proteome changes induced by oxidative stress in the developing brain. Cell Death Differ 2006; 13: 1097-1109.
8. Juul S, Felderhoff-Mueser U: Epo and other hematopoietic factors. Semin Fetal Neonatal Med 2007; 12: 250-258.
9. Kaindl AM, Sifringer M, Koppelstaetter A, Genz K, Loeber R, Boerner C, Stuwe J, Klose J, Felderhoff-Mueser U: Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann Neurol 2008; 64: 523-534.
10. Felderhoff-Mueser U, Sifringer M, Polley O, Dzietko M, Leineweber B, Mahler L, Baier M, Bittigau P, Obladen M, Ikonomidou C, Buehrer C: Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol 2005; 57: 50-59.
11. Sternlicht MD, Werb Z: How matrix metal-loproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
12. Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, Le Diguardher T, Khrestchatisky M, Rivera S: Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 2003; 18: 1507-1517.
13. Amantea D, Russo R, Gliozzi M, Fratto V, Berliocchi L, Bagetta G, Bernardi G, Corasaniti MT: Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat. Int Rev Neurobiol 2007; 82: 149-169.
14. Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F, Heumann R, Bührer C, Ikonomidou C, Hansen HH: Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 2004; 15: 177-187.
15. Sifringer M, Stefovska V, Zentner I, Hansen B, Stepulak A, Knaute C, Marzahn J, Ikono-midou C: The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol Dis 2007; 25: 526-535.
16. Demers EJ, McPherson RJ, Juul SE: Erythro-poietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 2005; 58: 297-301.
17. Sola A, Wen TC, Hamrick SE, Ferriero DM: Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 2005; 57:R110-R117.
18. Digicaylioglu M, Lipton SA: Erythropoietin-mediated neuroprotection involves crosstalk between Jak2 and NF-kappaB signalling cascades. Nature 2001; 412: 641-647.
19. Keller M, Yang J, Griesmaier E, Gorna A, Sarkozy G, Urbanek M, Gressens P, Simbruner G: Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis 2006; 24: 357-366.
20. Ghezzi P, Brines M: Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004; 11(suppl 1):S37-S44.
21. Sun Y, Calvert JW, Zhang JH: Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005; 36: 1672-1678.
22. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003; 198: 971-975.
23. Juul SE, McPherson RJ, Bammler TK, Wil-kerson J, Beyer RP, Farin FM: Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model. Dev Neurosci 2008; 30: 231-242.
24. Kumral A, Baskin H, Yesilirmak DC, Ergur BU, Aykan S, Genc S, Genc K, Yilmaz O, Tugyan K, Giray O, Duman N, Ozkan H: Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neonatology 2007; 92: 269-278.
25. Russo R, Siviglia E, Gliozzi M, Amantea D, Paoletti A, Berliocchi L, Bagetta G, Corasa-niti MT: Evidence implicating matrix metal-loproteinases in the mechanism underlying accumulation of IL-1beta and neuronal apoptosis in the neocortex of HIV/gp120-exposed rats. Int Rev Neurobiol 2007; 82: 407-421.
26. Cunningham LA, Wetzel M, Rosenberg GA: Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005; 50: 329-339.
27. Rosenberg GA: Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279-291.
28. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH: Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20: 1681-1689.
29. Wetzel M, Rosenberg GA, Cunningham LA: Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 2003; 18: 1050-1060.
30. Lee SR, Lo EH: Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J Cereb Blood Flow Metab 2004; 24: 720-727.
31. Wang L, Zhang ZG, Zhang RL, Gregg SR, Hozeska-Solgot A, LeTourneau Y, Wang Y, Chopp M: Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 2006; 26: 5996-6003.
32. Chan CY, Chen YS, Lee HH, Huang HS, Lai YL, Chen CF, Ma MC: Erythropoietin protects postischemic hearts by preventing extracellular matrix degradation: Role of Jak2-ERK pathway. Life Sci 2007; 81: 717-723.